Literature DB >> 10418806

Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.

.   

Abstract

The Food and Drug Administration (FDA) Modernization Act of 1997 called for FDA to review and assess the risk of all mercury-containing food and drugs. In line with this review, U.S. vaccine manufacturers responded to a December 1998 and April 1999 FDA request to provide more detailed information about the thimerosal content of their preparations that include this compound as a preservative. Thimerosal has been used as an additive to biologics and vaccines since the 1930s because it is very effective in killing bacteria used in several vaccines and in preventing bacterial contamination, particularly in opened multidose containers. Some but not all of the vaccines recommended routinely for children in the United States contain thimerosal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418806

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  19 in total

1.  The thimerosal insinuation.

Authors:  Anthony Scalzo; Kenneth Haller
Journal:  Mo Med       Date:  2012 Jan-Feb

2.  Autistic spectrum disorder: No causal relationship with vaccines.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-05       Impact factor: 2.253

3.  Autistic spectrum disorder: No causal relationship with vaccines.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-05       Impact factor: 2.471

Review 4.  Thiomersal in vaccines: is removal warranted?

Authors:  C J Clements; L K Ball; R Ball; R D Pratt
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 5.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 6.  Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.

Authors:  Mark Bigham; Ray Copes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001.

Authors:  Emily Jane Woo; Robert Ball; Ann Bostrom; Sean V Shadomy; Leslie K Ball; Geoffrey Evans; Miles Braun
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

Review 8.  Vaccine allergies.

Authors:  Eun Hee Chung
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

Review 9.  Vaccines and autism: a tale of shifting hypotheses.

Authors:  Jeffrey S Gerber; Paul A Offit
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

10.  Mercury exposure: medical and public health issues.

Authors:  Kathryn R Mahaffey
Journal:  Trans Am Clin Climatol Assoc       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.